About
Veriskin develops TruScore, a handheld, non-invasive diagnostic device that uses AI technology to rapidly and accurately screen for skin cancer at the frontline of healthcare.
Explore Veriskin's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.